SMO ClinPlus CO.,LTD. (SHE:301257)
China
· Delayed Price · Currency is CNY 30.12
+0.36 (1.21%)
At close: Jun 27, 2025, 2:57 PM CST
SMO ClinPlus CO.,LTD. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 803.73 | 760.04 | 586.23 | 502.97 | 335.29 | Upgrade
|
Other Revenue | - | 0 | 0 | - | - | Upgrade
|
| 803.73 | 760.04 | 586.23 | 502.97 | 335.29 | Upgrade
| |
Revenue Growth (YoY) | 5.75% | 29.65% | 16.55% | 50.01% | 10.46% | Upgrade
|
Cost of Revenue | 607.75 | 528.94 | 426.25 | 371.77 | 237.64 | Upgrade
|
Gross Profit | 195.98 | 231.1 | 159.98 | 131.19 | 97.65 | Upgrade
|
Selling, General & Admin | 52.37 | 50.28 | 49.86 | 33.74 | 39.5 | Upgrade
|
Research & Development | 35.84 | 34.75 | 32.23 | 21.19 | 14.99 | Upgrade
|
Other Operating Expenses | -7.31 | 5.18 | 2.99 | 2.94 | 1.08 | Upgrade
|
Operating Expenses | 83.98 | 100.58 | 91.25 | 63.71 | 59.57 | Upgrade
|
Operating Income | 112.01 | 130.52 | 68.73 | 67.49 | 38.08 | Upgrade
|
Interest Expense | - | -0.32 | -0.18 | -0.27 | - | Upgrade
|
Interest & Investment Income | 13.09 | 16.44 | 6.82 | 1.73 | 0.56 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | -1.75 | Upgrade
|
Other Non Operating Income (Expenses) | 2.61 | -0.48 | 0.19 | -0.52 | -0.15 | Upgrade
|
EBT Excluding Unusual Items | 127.7 | 146.16 | 75.56 | 68.42 | 36.74 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.58 | 1.14 | 0.84 | -1.47 | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.12 | 0.02 | 0.02 | -0.08 | -0.05 | Upgrade
|
Asset Writedown | -6.59 | -0.01 | -0 | -0 | -0 | Upgrade
|
Other Unusual Items | 0 | 13.72 | 4.41 | - | 4.83 | Upgrade
|
Pretax Income | 121.58 | 161.03 | 80.84 | 66.88 | 41.51 | Upgrade
|
Income Tax Expense | 15.15 | 26.3 | 8.43 | 9.11 | 6.19 | Upgrade
|
Net Income | 106.43 | 134.73 | 72.41 | 57.77 | 35.32 | Upgrade
|
Net Income to Common | 106.43 | 134.73 | 72.41 | 57.77 | 35.32 | Upgrade
|
Net Income Growth | -21.00% | 86.06% | 25.35% | 63.58% | -32.55% | Upgrade
|
Shares Outstanding (Basic) | 79 | 78 | 70 | 59 | 59 | Upgrade
|
Shares Outstanding (Diluted) | 79 | 79 | 71 | 59 | 59 | Upgrade
|
Shares Change (YoY) | -0.07% | 11.47% | 20.98% | - | - | Upgrade
|
EPS (Basic) | 1.35 | 1.72 | 1.04 | 0.99 | 0.60 | Upgrade
|
EPS (Diluted) | 1.35 | 1.71 | 1.02 | 0.98 | 0.60 | Upgrade
|
EPS Growth | -20.95% | 66.91% | 3.91% | 63.09% | -32.34% | Upgrade
|
Free Cash Flow | -10.29 | 104.6 | 32.48 | 37.11 | 18.36 | Upgrade
|
Free Cash Flow Per Share | -0.13 | 1.33 | 0.46 | 0.63 | 0.31 | Upgrade
|
Dividend Per Share | - | 0.180 | 0.083 | - | - | Upgrade
|
Dividend Growth | - | 116.61% | - | - | - | Upgrade
|
Gross Margin | 24.38% | 30.41% | 27.29% | 26.08% | 29.12% | Upgrade
|
Operating Margin | 13.94% | 17.17% | 11.72% | 13.42% | 11.36% | Upgrade
|
Profit Margin | 13.24% | 17.73% | 12.35% | 11.49% | 10.53% | Upgrade
|
Free Cash Flow Margin | -1.28% | 13.76% | 5.54% | 7.38% | 5.48% | Upgrade
|
EBITDA | 117.99 | 135.08 | 72.29 | 70.3 | 40.33 | Upgrade
|
EBITDA Margin | 14.68% | 17.77% | 12.33% | 13.98% | 12.03% | Upgrade
|
D&A For EBITDA | 5.98 | 4.55 | 3.56 | 2.81 | 2.25 | Upgrade
|
EBIT | 112.01 | 130.52 | 68.73 | 67.49 | 38.08 | Upgrade
|
EBIT Margin | 13.94% | 17.17% | 11.72% | 13.42% | 11.36% | Upgrade
|
Effective Tax Rate | 12.46% | 16.33% | 10.42% | 13.62% | 14.92% | Upgrade
|
Revenue as Reported | 803.73 | 760.04 | 586.23 | 502.97 | 335.29 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.